China Grants First Commercial Approval for ‘Brain Implant’ for Patients with Spinal Cord Injury and Limb Paralysis
China has become the first country to commercially approve a brain-computer interface device designed to assist patients with spinal cord injuries and limb paralysis.
National Lottery: check the draw of Thursday, March 19
Spain's National Lottery has a draw scheduled for March 19, 2026, featuring a top prize of 30,000 euros per ticket and celebrating the 35th anniversary of the Association of People with Spinal Cord Injury of Madrid.
Paralyzed individuals controlled a keyboard with their thoughts
Researchers have enabled paralyzed individuals to write on a screen using only their thoughts through an advanced brain-computer interface.
True Story: Neurologist Changed Treatment in the 1940s – The Consequences Can Be Seen This Friday on TV
The article discusses the impact of neurologist Ludwig Guttmann's revolutionary treatment methods for spinal cord injury patients in the 1940s, as highlighted in the film 'The Best of Men', coinciding with the current Winter Paralympics.
Polylaminin: why the study was not published by scientific journals and what the next steps of the research are
The study on polylaminin has faced publication rejection from scientific journals due to discrepancies in patient recovery rates and the lack of prior registration in an international research database.
The first to receive polylaminin in MG, woman says the medication is 'a sign of hope'
A woman from Governador Valadares, Brazil, became the first in Minas Gerais to receive an experimental treatment aimed at regenerating nerve connections after a spinal cord injury.
'Rehabilitation is decisive and cannot be sidelined in studies with polylaminin,' says doctor
A Brazilian doctor emphasizes the importance of prioritizing rehabilitation in the clinical studies of polylaminin, a substance being tested for acute spinal cord injury treatment.
Article about polylaminin has errors and will be revised, says researcher to newspaper
Biologist Tatiana Coelho de Sampaio announces that errors in a pre-print article on polylaminin as a treatment for spinal cord injury will be corrected before resubmission to scientific journals.
Patient who lost movement receives treatment with polylaminin in Salvador: 'Rekindled my faith'
A 38-year-old logistics operator in Salvador receives an experimental treatment for spinal cord injury using polylaminin at a private hospital, marking a significant step in medical research in Brazil.
Polilaminin: hospital in the interior of SP provides placentas for the production of a substance tested in the treatment of spinal cord injuries
A hospital in Itapira, São Paulo, is collecting placenta donations to produce polilaminin, a substance currently being tested for the treatment of acute spinal cord injuries.
Ethics Committee of HC-USP denies experimental use of polylaminin on sergeant who was shot and injured spinal cord
The Medical Ethics Committee at the Hospital das ClÃnicas, USP, denied the request for experimental treatment with polylaminin for a police sergeant who suffered a severe spinal cord injury.
Tatiana Sampaio, researcher of polylaminin, will be honored by Alerj
Tatiana Sampaio, a researcher from UFRJ, will receive the Benemérita title from the State of Rio de Janeiro for her work on polylaminin, an experimental substance for spinal cord injury treatment.
'I want to be like before,' says the 1st young person from MT to receive polylaminin in experimental study
'I want to be like before,' says a 21-year-old from Rondonópolis, Brazil who is the first in his state to participate in an experimental treatment for spinal cord injuries using polylaminin.
Polylaminin is not yet a drug: specialists warn against 'hype' on social media
Experts caution that the biotechnological compound polylaminin, popularized for its potential in treating spinal cord injuries, is still unproven and should not be considered a cure.
Use of polylaminin is monitored in real time by society: 'Like a Big Brother', says researcher
Research on polylaminin, a substance being studied as a possible treatment for spinal cord injuries, is closely monitored by society, according to lead researcher Tatiana Sampaio.
How long will it take for us to know the effectiveness of polylaminin? Understand the substance in 16 topics
Polylaminin has generated significant attention on social media due to its association with reports of patient recovery, but experts urge caution due to a lack of robust clinical evidence supporting its efficacy and safety.
Delegate who survived accident with police vehicle receives dose of polylaminin in an attempt to walk again
Delegate Leonardo Sanches, paralyzed after a car accident, has received polylaminin treatment, becoming the first individual in Goiás to access this potentially life-altering therapy.
Polylaminin: How the studies were conducted, what are the results so far, and what does Anvisa say? Understand
A groundbreaking Brazilian study on polylaminin shows promising results in restoring movement after severe injuries, with a pivotal clinical study approved by Anvisa set to begin next month.
'Self-promotion with little scientific methodology', says reader about medication for patients with spinal cord injury
A reader critiques the promotion of a medication for spinal cord injury patients, arguing it lacks sufficient scientific backing.
Neurologists alert to lack of evidence on the action of poly-L-lysine in spinal cord injury
Brazilian neurologists warn about insufficient scientific evidence supporting the use of poly-L-lysine for treating spinal cord injuries in humans.
Polylaminin: Maranhão native who received the substance begins home treatment and shows improvement
Hector Lucena, a 26-year-old agronomy student from Balsas, Maranhão, has begun at-home treatment with polylaminin for spinal cord trauma and reports improvements in his health.
VIDEO: Reporter Flávia Cintra hugs biologist Tatiana Sampaio, researcher leading studies on polylaminin
Reporter Flávia Cintra shares an emotional moment with biologist Tatiana Sampaio during a segment on the substance polylaminin, which offers hope for those with spinal cord injuries, going viral on social media.
This is Fantastic: the advances in experimental treatments with polylaminin
The article discusses promising advancements in experimental treatments involving polylaminin, a placenta-derived protein that may restore movement in patients with severe spinal cord injuries.
VIDEO: João Gomes interrupts show in Sapucaà to honor scientist leading research on polylaminin
Singer João Gomes interrupted a performance to pay tribute to researcher Tatiana Sampaio, who is recognized for her work on polylaminin for treating acute spinal cord injuries.
Scientific societies call for caution and precision in the debate over poly-laminin
Scientific societies in Brazil urge caution in the discussion surrounding poly-laminin, a protein under investigation for spinal cord injury regeneration, emphasizing the importance of distinguishing experimental research from established clinical application.
Polylaminin and Tatiana Sampaio go viral on social media, but fall well below Virginia, says survey
Biologist Tatiana Sampaio has gained 16 million interactions on social media, receiving significant attention for her research on polylaminin, a protein aimed at aiding spinal cord injury regeneration.
Patient walks again and polylaminin trends; understand what the substance can do and what is still unknown
Polylaminin has recently gained attention on social media due to a patient's recovery and ongoing discussions about its potential and patent issues in Brazil.
Claes Hultling: That's why we had a sex room at the Spinal Clinic
Claes Hultling, a 31-year-old anesthesiologist, reflects on his transformative experience as a patient after a life-changing injury and shares his innovative ideas for the treatment of spinal cord injuries.
Tatiana Sampaio, scientist who developed a molecule that can reverse spinal cord injuries, participates in event at IFTM in PatrocÃnio
Tatiana Sampaio, a leading researcher in spinal cord injury recovery, will participate in the 'Extraordinary Women' event at the IFTM in PatrocÃnio, Brazil.
"Dancing Therapy" Restores Spinal Cord Injury in the Laboratory
Researchers at Northwestern University created the most detailed spinal cord model to date in the lab, inducing injury and subsequently treating it with 'dancing molecules.'
Polylaminin: a molecule discovered in Brazil 'by chance' that became hope to reverse spinal cord injuries
Polylaminin, a modified version of the naturally occurring laminin protein, is being studied as a new potential treatment for spinal cord injury victims in Brazil, although it is still in early clinical trial phases.
Podcast: the Brazilian experimental drug that may be hope for spinal cord injuries
The podcast discusses polylaminin, an experimental drug showing promise in restoring movement for patients with spinal cord injuries, highlighted by the case of a Brazilian influencer who regained arm movement after treatment.